The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

Share Price Information for Walker Crips (WCW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 22.50
WCW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of the Disposal of WCAM

13 Apr 2012 07:00

RNS Number : 2614B
Walker Crips Group plc
13 April 2012
 



13 April 2012

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO US PERSONS, OR INTO THE UNITED STATES, OR INTO OR FROM CANADA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

WALKER CRIPS GROUP PLC

("Walker Crips" or the "Company")

Completion of the Disposal of WCAMandDirectorate Changes

 

Further to the announcement made on 5 April 2012, Walker Crips Group plc, the financial services group, is pleased to confirm that approval from the FSA has been received in respect of a change in controller of WCAM to Liontrust and that all remaining conditions to the SPA have now been satisfied. Accordingly, Completion has taken place.

As previously announced, Stephen Bailey has resigned from his position as a director of the Company effective immediately.

The Company is also pleased to announce the appointment of its Chief Investment Officer, Mark Justin Wells Rushton, to the Company's Board. Mr. Rushton, 49, will take up his additional executive responsibilities to the Board effective immediately.

In the last five years, Mr. Rushton has held the following directorships:

 

Current directorships

Previous directorships

None

Endeavour Trading Ltd

There is no further information relating to Mr Rushton's appointment requiring disclosure under 9.6.13R of the Listing Rules.

The Company was notified on 10 April 2012 that Mark purchased 25,000 Ordinary Shares in the capital of the Company on 10 April 2012 at a price of 45p per Ordinary Share. Accordingly, as at the date of this announcement, Mark Rushton is interested in a total of 25,000 Ordinary Shares in the capital of the Company, representing an interest of 0.07 per cent. of the total voting rights of the Company.

 

For further information please contact:

Rodney FitzGerald, CEO

Walker Crips Group plc

www.wcgplc.co.uk

+44 (0) 20 3100 8000

Gordon NeillyRishi Zaveri

Canaccord Genuity Limited

www.canaccordgenuity.com

+44 (0) 20 7050 6778+44 (0) 20 7050 6780

Media enquiries:

Geri Jacks

Walker Crips Group plcwww.wcgplc.co.uk

+44 (0) 20 3100 8000

Notes:

Unless the context otherwise requires, defined terms used in this announcement shall have the meanings ascribed to them in the Company's circular to Shareholders dated 13 March 2012.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as sponsor and financial adviser exclusively for the Company in connection with the Disposal. Canaccord Genuity Limited is not acting for any other person and will not be responsible to any other person for providing the protections afforded to clients of Canaccord Genuity Limited or for advising any other person in connection with the Disposal.

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKBDPNBKBAQD
Date   Source Headline
29th May 201912:01 pmRNSDirector/PDMR Shareholding
21st May 20195:15 pmRNSDirector/PDMR Shareholding
8th May 201911:30 amRNSDirector/PDMR Shareholding
27th Mar 20196:30 pmRNSDirector/PDMR Shareholding
13th Mar 20195:53 pmRNSReplacement Director/PDMR Shareholding
13th Mar 201912:53 pmRNSDirector/PDMR Shareholding
7th Mar 20194:52 pmRNSDirector/PDMR Shareholding
4th Mar 20198:44 amRNSDirector/PDMR Shareholding
1st Mar 20193:56 pmRNSDirector/PDMR Shareholding
26th Feb 20194:00 pmRNSTrading Update
12th Feb 20194:56 pmRNSDirector / PDMR Shareholdings
30th Jan 20197:00 amRNSBoard changes
17th Dec 201812:00 pmRNSDirector/PDMR Shareholding
27th Nov 20188:36 amRNSHalf-year Report - Replacement
27th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
29th Oct 201811:25 amRNSDirector/PDMR Shareholding
11th Oct 20182:53 pmRNSDirector/PDMR Shareholding
20th Sep 201811:10 amRNSDirector/PDMR Shareholding
14th Sep 20185:24 pmRNSDirector/PDMR Shareholding
5th Sep 20184:33 pmRNSResult of AGM
31st Jul 20184:08 pmRNSFinal Results
8th Jun 20183:28 pmRNSDirector/PDMR Shareholding
25th May 20187:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20188:20 amRNSHolding(s) in Company
18th Apr 20185:34 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHolding(s) in Company
6th Mar 20185:36 pmRNSHolding(s) in Company
19th Feb 20183:30 pmRNSDirector/PDMR Shareholding
9th Feb 20184:55 pmRNSDirectorate Change
4th Jan 201810:10 amRNSDirector/PDMR Shareholding
21st Dec 201710:10 amRNSDirector/PDMR Shareholding
13th Dec 201712:31 pmRNSHolding(s) in Company
13th Dec 201712:30 pmRNSDirector / PDMR Shareholdings
11th Dec 20178:24 amRNSDirector/PDMR Shareholding
1st Dec 20175:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20177:00 amRNSHalf-year Report
13th Oct 20177:00 amRNSIssue of Equity and Total Voting Rights
6th Sep 20174:02 pmRNSResult of AGM
31st Aug 20177:00 amRNSBoard changes
18th Jul 20177:00 amRNSAnnual Financial Results
22nd May 20171:41 pmRNSDirector/PDMR Shareholding
12th May 20177:00 amRNSIssue of Equity and Total Voting Rights
24th Mar 20175:09 pmRNSDirectorate Change
15th Mar 20177:00 amRNSSale of Fund Management Contract
9th Mar 20175:53 pmRNSHolding(s) in Company
9th Mar 20175:52 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSIssue of Equity and Total Voting Rights
3rd Mar 20173:13 pmRNSForm 8.3 - Clinical Computing
3rd Mar 20173:11 pmRNSForm 8.3 - Clinical Computing re Ian Amiee
21st Dec 201612:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.